We are a newly organized blank check company. (Incorporated in the Cayman Islands) We intend to focus on identifying a business combination target within the experiential entertainment industry across both location-based (in-person) and mobile channels. Select sectors that we intend to target span live events, integrated resorts, family entertainment, casinos, destination hospitality, amusement parks, dining, sports […]

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We intend to target the financial services and real estate sectors, which we believe are at a pivotal moment of transformation and will offer compelling investment opportunities for the foreseeable future.   (Note: Rithm Acquisition Corp. priced its SPAC IPO on Feb. […]

(Incorporated in the Cayman Islands)  Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance […]

(Incorporated in the Cayman Islands)  We are a blank check company. We currently intend to concentrate our efforts on identifying companies in either the technology or lifestyle sectors. We intend to focus our search for a business combination partner in the Asia Pacific (excluding the PRC) and North American regions. Certain of our executive officers and […]

We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients. (Incorporated in Delaware) An estimated 106,000 people have been diagnosed […]

Note: Odyssey Therapeutics withdrew its IPO plans in a letter to the SEC dated June 10, 2025. Odyssey, a clinical biotech focused on autoimmune and inflammatory diseases, including ulcerative colitis, filed its S-1 on Jan. 17, 2025, without disclosing the IPO’s terms. Odyssey is a clinical-stage biopharmaceutical company led by a team and board of […]

(Note: This is a NASDAQ uplisting – a public offering – and NOT an IPO. The stock currently trades on the OTCQB.) We are a pioneer in the development, production and marketing of an innovative visualization and artificial intelligence, or AI, solution that deploys small cameras to monitor critical safety components in hard-to-reach locations and […]

(Incorporated in Delaware) Note: Wellgistics Health (WGRX Proposed) was formerly known as Danam Health.  Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division […]

We are a newly organized blank check company. (Incorporated in the Cayman Islands) We were founded by two Greek shipping executives, Prokopios Tsirigakis and George Syllantavos. They are the co-CEOs of Nautilus Energy Management, a maritime energy services company.  (Note: Stellar V Capital Corp. disclosed the terms for its SPAC IPO on Dec. 4, 2024, in […]

We are a clinical biopharmaceutical company developing MET-097i as an injectable treatment for obesity in a Phase I/Phase 2 clinical trial with overweight or obese healthy volunteers. (Incorporated in Delaware) We are developing next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Obesity and overweight are […]